Captopril vs Durvalumab
Captopril vs Durvalumab: Overview
This comparison examines the pharmacological differences between Captopril and Durvalumab.
Mechanism of Action
Captopril: First orally active ACE inhibitor; contains thiol group that binds zinc at ACE active site.
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Pharmacokinetics
Half-life: Captopril — 1.9 hours; Durvalumab — 17 days.
Chemical Properties
Molecular Formula: Captopril — C9H15NO3S.
Molecular Weight: Captopril — 217.2850 g/mol.
Type: Captopril — Small molecule; Durvalumab — Antibody.